Chemoinformaics analysis of 3alpha-Tigloyloxytropane
| Molecular Weight | 223.316 | nRot | 2 |
| Heavy Atom Molecular Weight | 202.148 | nRig | 11 |
| Exact Molecular Weight | 223.157 | nRing | 2 |
| Solubility: LogS | -1.959 | nHRing | 2 |
| Solubility: LogP | 1.88 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 38.4167 |
| nHD | 0 | BPOL | 25.3813 |
| QED | 0.53 |
| Synth | 4.107 |
| Natural Product Likeliness | 1.817 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.03 |
| HIA | 0.004 |
| CACO-2 | -4.447 |
| MDCK | 0.0000219 |
| BBB | 0.494 |
| PPB | 0.393632 |
| VDSS | 4.308 |
| FU | 0.590054 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.21 |
| CYP2c19-inh | 0.069 |
| CYP2c19-sub | 0.91 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.142 |
| CYP2d6-inh | 0.944 |
| CYP2d6-sub | 0.804 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.692 |
| CL | 11.879 |
| T12 | 0.596 |
| hERG | 0.323 |
| Ames | 0.023 |
| ROA | 0.103 |
| SkinSen | 0.911 |
| Carcinogencity | 0.12 |
| EI | 0.034 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.833553 |